nodes	percent_of_prediction	percent_of_DWPC	metapath
Altretamine—Alkylating Activity—Thiotepa—sarcoma	0.532	0.556	CiPCiCtD
Altretamine—Alkylating Activity—Dacarbazine—sarcoma	0.425	0.444	CiPCiCtD
Altretamine—Affective disorder—Mitoxantrone—sarcoma	0.00513	0.12	CcSEcCtD
Altretamine—Neurotoxicity—Vincristine—sarcoma	0.0017	0.0398	CcSEcCtD
Altretamine—Myelosuppression—Thiotepa—sarcoma	0.00159	0.0371	CcSEcCtD
Altretamine—Myelosuppression—Dactinomycin—sarcoma	0.00158	0.0368	CcSEcCtD
Altretamine—Myelosuppression—Vincristine—sarcoma	0.00141	0.0329	CcSEcCtD
Altretamine—Neurotoxicity—Etoposide—sarcoma	0.00138	0.0322	CcSEcCtD
Altretamine—Myelosuppression—Mitoxantrone—sarcoma	0.00137	0.032	CcSEcCtD
Altretamine—Myelosuppression—Etoposide—sarcoma	0.00114	0.0266	CcSEcCtD
Altretamine—Peripheral sensory neuropathy—Epirubicin—sarcoma	0.00105	0.0245	CcSEcCtD
Altretamine—Peripheral sensory neuropathy—Doxorubicin—sarcoma	0.000971	0.0227	CcSEcCtD
Altretamine—Neoplasm malignant—Thiotepa—sarcoma	0.000872	0.0204	CcSEcCtD
Altretamine—Neurotoxicity—Epirubicin—sarcoma	0.000773	0.0181	CcSEcCtD
Altretamine—Neurotoxicity—Doxorubicin—sarcoma	0.000716	0.0167	CcSEcCtD
Altretamine—Myelosuppression—Epirubicin—sarcoma	0.000639	0.0149	CcSEcCtD
Altretamine—Blood alkaline phosphatase increased—Thiotepa—sarcoma	0.000621	0.0145	CcSEcCtD
Altretamine—Myelosuppression—Doxorubicin—sarcoma	0.000592	0.0138	CcSEcCtD
Altretamine—Phosphatase alkaline increased—Etoposide—sarcoma	0.000535	0.0125	CcSEcCtD
Altretamine—Ataxia—Thiotepa—sarcoma	0.000508	0.0119	CcSEcCtD
Altretamine—Ataxia—Vincristine—sarcoma	0.000451	0.0105	CcSEcCtD
Altretamine—Blood alkaline phosphatase increased—Etoposide—sarcoma	0.000446	0.0104	CcSEcCtD
Altretamine—Pancytopenia—Thiotepa—sarcoma	0.000444	0.0104	CcSEcCtD
Altretamine—Pancytopenia—Dactinomycin—sarcoma	0.00044	0.0103	CcSEcCtD
Altretamine—Pancytopenia—Vincristine—sarcoma	0.000393	0.00919	CcSEcCtD
Altretamine—Pancytopenia—Mitoxantrone—sarcoma	0.000383	0.00895	CcSEcCtD
Altretamine—Neuropathy peripheral—Vincristine—sarcoma	0.000362	0.00846	CcSEcCtD
Altretamine—Neoplasm malignant—Epirubicin—sarcoma	0.000351	0.0082	CcSEcCtD
Altretamine—Neoplasm malignant—Doxorubicin—sarcoma	0.000325	0.00759	CcSEcCtD
Altretamine—Pancytopenia—Etoposide—sarcoma	0.000319	0.00745	CcSEcCtD
Altretamine—Anaemia—Thiotepa—sarcoma	0.000301	0.00703	CcSEcCtD
Altretamine—Phosphatase alkaline increased—Epirubicin—sarcoma	0.0003	0.007	CcSEcCtD
Altretamine—Anaemia—Dactinomycin—sarcoma	0.000299	0.00698	CcSEcCtD
Altretamine—Neuropathy peripheral—Etoposide—sarcoma	0.000293	0.00685	CcSEcCtD
Altretamine—Leukopenia—Thiotepa—sarcoma	0.000291	0.00681	CcSEcCtD
Altretamine—Leukopenia—Dactinomycin—sarcoma	0.000289	0.00676	CcSEcCtD
Altretamine—Convulsion—Thiotepa—sarcoma	0.000282	0.00659	CcSEcCtD
Altretamine—Phosphatase alkaline increased—Doxorubicin—sarcoma	0.000277	0.00648	CcSEcCtD
Altretamine—Neoplasm—Epirubicin—sarcoma	0.000271	0.00633	CcSEcCtD
Altretamine—Anaemia—Vincristine—sarcoma	0.000267	0.00623	CcSEcCtD
Altretamine—Thrombocytopenia—Thiotepa—sarcoma	0.00026	0.00608	CcSEcCtD
Altretamine—Anaemia—Mitoxantrone—sarcoma	0.00026	0.00607	CcSEcCtD
Altretamine—Vertigo—Vincristine—sarcoma	0.000259	0.00606	CcSEcCtD
Altretamine—Leukopenia—Vincristine—sarcoma	0.000258	0.00604	CcSEcCtD
Altretamine—Thrombocytopenia—Dactinomycin—sarcoma	0.000258	0.00603	CcSEcCtD
Altretamine—Anorexia—Thiotepa—sarcoma	0.000253	0.00592	CcSEcCtD
Altretamine—Leukopenia—Mitoxantrone—sarcoma	0.000252	0.00588	CcSEcCtD
Altretamine—Anorexia—Dactinomycin—sarcoma	0.000251	0.00587	CcSEcCtD
Altretamine—Neoplasm—Doxorubicin—sarcoma	0.000251	0.00586	CcSEcCtD
Altretamine—Blood alkaline phosphatase increased—Epirubicin—sarcoma	0.00025	0.00585	CcSEcCtD
Altretamine—Convulsion—Vincristine—sarcoma	0.00025	0.00584	CcSEcCtD
Altretamine—Convulsion—Mitoxantrone—sarcoma	0.000244	0.00569	CcSEcCtD
Altretamine—Blood alkaline phosphatase increased—Doxorubicin—sarcoma	0.000232	0.00541	CcSEcCtD
Altretamine—Decreased appetite—Thiotepa—sarcoma	0.000231	0.0054	CcSEcCtD
Altretamine—Thrombocytopenia—Vincristine—sarcoma	0.000231	0.00539	CcSEcCtD
Altretamine—Decreased appetite—Dactinomycin—sarcoma	0.000229	0.00535	CcSEcCtD
Altretamine—Fatigue—Thiotepa—sarcoma	0.000229	0.00535	CcSEcCtD
Altretamine—Fatigue—Dactinomycin—sarcoma	0.000227	0.00531	CcSEcCtD
Altretamine—Thrombocytopenia—Mitoxantrone—sarcoma	0.000225	0.00525	CcSEcCtD
Altretamine—Anorexia—Vincristine—sarcoma	0.000225	0.00525	CcSEcCtD
Altretamine—Anorexia—Mitoxantrone—sarcoma	0.000219	0.00511	CcSEcCtD
Altretamine—Anaemia—Etoposide—sarcoma	0.000216	0.00505	CcSEcCtD
Altretamine—Vertigo—Etoposide—sarcoma	0.00021	0.00491	CcSEcCtD
Altretamine—Leukopenia—Etoposide—sarcoma	0.000209	0.00489	CcSEcCtD
Altretamine—Decreased appetite—Vincristine—sarcoma	0.000205	0.00478	CcSEcCtD
Altretamine—Ataxia—Epirubicin—sarcoma	0.000205	0.00478	CcSEcCtD
Altretamine—Fatigue—Vincristine—sarcoma	0.000203	0.00474	CcSEcCtD
Altretamine—Convulsion—Etoposide—sarcoma	0.000203	0.00473	CcSEcCtD
Altretamine—Decreased appetite—Mitoxantrone—sarcoma	0.000199	0.00466	CcSEcCtD
Altretamine—Fatigue—Mitoxantrone—sarcoma	0.000198	0.00462	CcSEcCtD
Altretamine—Asthenia—Thiotepa—sarcoma	0.000191	0.00445	CcSEcCtD
Altretamine—Ataxia—Doxorubicin—sarcoma	0.000189	0.00442	CcSEcCtD
Altretamine—Asthenia—Dactinomycin—sarcoma	0.000189	0.00442	CcSEcCtD
Altretamine—Thrombocytopenia—Etoposide—sarcoma	0.000187	0.00436	CcSEcCtD
Altretamine—Anorexia—Etoposide—sarcoma	0.000182	0.00425	CcSEcCtD
Altretamine—Pancytopenia—Epirubicin—sarcoma	0.000179	0.00417	CcSEcCtD
Altretamine—Dizziness—Thiotepa—sarcoma	0.000176	0.0041	CcSEcCtD
Altretamine—Asthenia—Vincristine—sarcoma	0.000169	0.00395	CcSEcCtD
Altretamine—Vomiting—Thiotepa—sarcoma	0.000169	0.00395	CcSEcCtD
Altretamine—Vomiting—Dactinomycin—sarcoma	0.000168	0.00392	CcSEcCtD
Altretamine—Decreased appetite—Etoposide—sarcoma	0.000166	0.00388	CcSEcCtD
Altretamine—Pancytopenia—Doxorubicin—sarcoma	0.000165	0.00386	CcSEcCtD
Altretamine—Asthenia—Mitoxantrone—sarcoma	0.000165	0.00385	CcSEcCtD
Altretamine—Fatigue—Etoposide—sarcoma	0.000165	0.00384	CcSEcCtD
Altretamine—Neuropathy peripheral—Epirubicin—sarcoma	0.000164	0.00384	CcSEcCtD
Altretamine—Nausea—Thiotepa—sarcoma	0.000158	0.00369	CcSEcCtD
Altretamine—Nausea—Dactinomycin—sarcoma	0.000157	0.00366	CcSEcCtD
Altretamine—Dizziness—Vincristine—sarcoma	0.000156	0.00364	CcSEcCtD
Altretamine—Neuropathy peripheral—Doxorubicin—sarcoma	0.000152	0.00355	CcSEcCtD
Altretamine—Vomiting—Vincristine—sarcoma	0.00015	0.0035	CcSEcCtD
Altretamine—Vomiting—Mitoxantrone—sarcoma	0.000146	0.00341	CcSEcCtD
Altretamine—Nausea—Vincristine—sarcoma	0.00014	0.00327	CcSEcCtD
Altretamine—Asthenia—Etoposide—sarcoma	0.000137	0.0032	CcSEcCtD
Altretamine—Nausea—Mitoxantrone—sarcoma	0.000136	0.00318	CcSEcCtD
Altretamine—Dizziness—Etoposide—sarcoma	0.000126	0.00295	CcSEcCtD
Altretamine—Vomiting—Etoposide—sarcoma	0.000121	0.00283	CcSEcCtD
Altretamine—Anaemia—Epirubicin—sarcoma	0.000121	0.00283	CcSEcCtD
Altretamine—Vertigo—Epirubicin—sarcoma	0.000118	0.00275	CcSEcCtD
Altretamine—Leukopenia—Epirubicin—sarcoma	0.000117	0.00274	CcSEcCtD
Altretamine—Convulsion—Epirubicin—sarcoma	0.000114	0.00265	CcSEcCtD
Altretamine—Nausea—Etoposide—sarcoma	0.000113	0.00265	CcSEcCtD
Altretamine—Anaemia—Doxorubicin—sarcoma	0.000112	0.00262	CcSEcCtD
Altretamine—Vertigo—Doxorubicin—sarcoma	0.000109	0.00255	CcSEcCtD
Altretamine—Leukopenia—Doxorubicin—sarcoma	0.000109	0.00254	CcSEcCtD
Altretamine—Convulsion—Doxorubicin—sarcoma	0.000105	0.00245	CcSEcCtD
Altretamine—Thrombocytopenia—Epirubicin—sarcoma	0.000105	0.00245	CcSEcCtD
Altretamine—Anorexia—Epirubicin—sarcoma	0.000102	0.00238	CcSEcCtD
Altretamine—Thrombocytopenia—Doxorubicin—sarcoma	9.69e-05	0.00226	CcSEcCtD
Altretamine—Anorexia—Doxorubicin—sarcoma	9.44e-05	0.0022	CcSEcCtD
Altretamine—Decreased appetite—Epirubicin—sarcoma	9.3e-05	0.00217	CcSEcCtD
Altretamine—Fatigue—Epirubicin—sarcoma	9.22e-05	0.00215	CcSEcCtD
Altretamine—Decreased appetite—Doxorubicin—sarcoma	8.6e-05	0.00201	CcSEcCtD
Altretamine—Fatigue—Doxorubicin—sarcoma	8.53e-05	0.00199	CcSEcCtD
Altretamine—Asthenia—Epirubicin—sarcoma	7.68e-05	0.00179	CcSEcCtD
Altretamine—Asthenia—Doxorubicin—sarcoma	7.1e-05	0.00166	CcSEcCtD
Altretamine—Dizziness—Epirubicin—sarcoma	7.07e-05	0.00165	CcSEcCtD
Altretamine—Vomiting—Epirubicin—sarcoma	6.8e-05	0.00159	CcSEcCtD
Altretamine—Dizziness—Doxorubicin—sarcoma	6.55e-05	0.00153	CcSEcCtD
Altretamine—Nausea—Epirubicin—sarcoma	6.35e-05	0.00148	CcSEcCtD
Altretamine—Vomiting—Doxorubicin—sarcoma	6.29e-05	0.00147	CcSEcCtD
Altretamine—Nausea—Doxorubicin—sarcoma	5.88e-05	0.00137	CcSEcCtD
